Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Dementia l: Introduction

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

Association Areas of the Cortex

Association Areas of the Cortex

Association areas are regions of the cerebral cortex that do not have a specific sensory or motor function. Instead, they integrate and interpret information from various sources to enable higher cognitive processes such as memory, learning, and decision-making. Some key association areas include the following:
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Anxiety in Dementia With Lewy Bodies.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026

Same author

From schizophrenia to dementia: Is Cobenfy a potential treatment for behavioral and psychological symptoms of dementia?

The Journal of international medical research·2026

Same author

Fundamentals of healthcare delivery science for the non-health systems scientist: the final step in translational research for late-life psychiatric and neurocognitive disorders.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026

Same author

Dronabinol for Agitation in Alzheimer's Disease.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2025

Same author

Antipsychotics for older adults with schizophrenia.

The lancet. Psychiatry·2025

Same author

Response for: Possible errors in "Electroconvulsive therapy in individuals with dementia/major NCD presenting with behavioral symptoms: A systematic review" [Int Psychogeriatr 36 (2024) 864-879].

International psychogeriatrics·2025

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Frontotemporal dementias: a review.

Natalie D Weder¹, Rehan Aziz, Kirsten Wilkins

¹Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. natalie.weder@yale.edu

Annals of General Psychiatry

|June 15, 2007

Summary

Frontotemporal dementia (FTD) is a progressive brain disorder affecting cognition and behavior, often mistaken for Alzheimer's disease. Early diagnosis and varied treatments can help manage FTD symptoms and improve patient quality of life.

More Related Videos

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

Related Experiment Videos

Last Updated: Jul 14, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

Area of Science:

Neurology
Neuroscience
Geriatrics

Background:

Dementia impacts cognitive functions, causing significant personal and economic burdens.
Frontotemporal dementia (FTD) is a key non-Alzheimer's dementia type, marked by frontal and temporal lobe atrophy.
FTD typically affects individuals aged 35-75, with increased prevalence in those with a family history.

Purpose of the Study:

To provide an overview of Frontotemporal Dementia (FTD).
To describe the clinical presentations, risk factors, and diagnostic methods for FTD.
To discuss current and future therapeutic strategies for FTD.

Main Methods:

Review of clinical characteristics and diagnostic criteria for FTD.
Analysis of prevalence, risk factors, and genetic predispositions.
Examination of current treatment modalities, including behavioral and pharmacological interventions.

Main Results:

FTD presents with three main variants: behavioral variant (FvFTD), semantic dementia (SD), and progressive aphasia (PA).
Diagnosis relies on neuropsychiatric assessment, neuropsychological testing, and neuroimaging.
Treatment involves behavioral management and medications like SSRIs, antipsychotics, and mood stabilizers, with varying success rates.

Conclusions:

FTD is a significant dementia subtype requiring accurate diagnosis through comprehensive assessments.
Management strategies include behavioral interventions and pharmacological treatments, though further research is needed.
Future research should focus on novel diagnostic and therapeutic approaches to enhance patient outcomes and quality of life.